Kamil Ali Jackson Rigel Pharmaceuticals Inc (RIGL) insider trading activity

Kamil Ali Jackson is of RIGEL PHARMACEUTICALS INC. Currently has a direct ownership of 9,375 shares of RIGL, which is worth approximately $201,843. The most recent transaction as insider was on May 23, 2025, when has been sold 2,500 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 9.38K

86.36% 3M change

86.36% 12M change

Total Value Held $201,843

Kamil Ali-Jackson Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 23 2025	BUY Grant, award, or other acquisition	-	2,500 Added 21.05%	9,375 Common Stock
May 25 2024	BUY Grant, award, or other acquisition	-	25,000 Added 26.67%	68,750 Common Stock
May 26 2023	BUY Grant, award, or other acquisition	-	25,000 Added 36.36%	43,750 Common Stock
May 20 2022	BUY Grant, award, or other acquisition	-	18,750 Added 50.0%	18,750 Common Stock

Also insider at

ACRS

Aclaris Therapeutics, Inc. Healthcare

Chief Legal Officer

PDSB

PDS Biotechnology Corp Healthcare